APPLIED GENETIC TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 19 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-11-19: Reporting owner ORONSKY ARNOLD L; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-11-19: Reporting owner Rosen James; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-11-19: Reporting owner Koenig Scott; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-11-19: Reporting owner PEACOCK BRUCE; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-11-19 | ORONSKY ARNOLD L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,200 6,200 owned after | $16.06 exercise price | 2015-12-04 | |
| 2015-11-19 | Rosen James Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,200 6,200 owned after | $16.06 exercise price | 2015-12-04 | |
| 2015-11-19 | Koenig Scott Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,200 6,200 owned after | $16.06 exercise price | 2015-12-04 | |
| 2015-11-19 | PEACOCK BRUCE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,200 6,200 owned after | $16.06 exercise price | 2015-12-04 | |
| 2015-11-19 | Magovcevic Ivana Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,200 6,200 owned after | $16.06 exercise price | 2015-12-04 | |
| 2015-11-19 | HURWITZ EDWARD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,200 6,200 owned after | $16.06 exercise price | 2015-12-04 | |
| 2015-07-21 | Shearman Mark S Officer (Chief Scientific Officer) | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 51,000 owned after | $18.48 exercise price | 2015-08-24 | |
| 2015-07-21 | Potter Stephen W Officer (See Remarks) | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 51,000 owned after | $18.48 exercise price | 2015-08-24 | |
| 2015-07-21 | Chulay Jeffrey D. Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +71,000 71,000 owned after | $18.48 exercise price | 2015-07-23 | |
| 2015-07-21 | Washer Susan B. Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $18.48 exercise price | 2015-07-23 | |
| 2015-07-21 | Shearman Mark S Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 51,000 owned after | $18.48 exercise price | 2015-07-23 | |
| 2015-07-21 | BULLOCK LAWRENCE E Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,000 37,000 owned after | $18.48 exercise price | 2015-07-23 | |
| 2015-07-21 | Potter Stephen W Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 51,000 owned after | $18.48 exercise price | 2015-07-23 | |
| 2015-06-01 | Shearman Mark S Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $19.50 exercise price | 2015-06-02 | |
| 2015-03-18 | PEACOCK BRUCE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $22.64 exercise price | 2015-03-20 | |
| 2015-03-09 | Chulay Jeffrey D. Officer (VP and Chief Medical Officer) | 5 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 30,511 owned after | $0.35 exercise price | 2015-08-14 | |
| 2015-01-29 | Chulay Jeffrey D. Officer (VP and Chief Medical Officer) | 5 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 30,511 owned after | $0.35 exercise price | 2015-08-14 | |
| 2015-01-29 | Potter Stephen W Officer (VP and Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +131,049 131,049 owned after | $24.62 exercise price | 2015-02-02 | |
| 2015-01-23 | Menichella Daniel L Officer (V.P. & Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,996 115,972 owned after | $4.90 exercise price | 2015-01-26 |